User profiles for Rosella Silvestrini

Rosella Silvestrini

Meldola, Milano, Forlì
Verified email at istitutotumori.mi.it
Cited by 10275

Labeling index as a prognostic marker in non-Hodgkin's lymphomas

…, E Villa, P Valagussa, R Silvestrini - Journal of the …, 1981 - academic.oup.com
The labeling index (LI) was determined at the time of initial diagnosis of 88 untreated adults
with non-Hodgkin's lymphomas. The frequency distribution of low (≤4%) and high (>4%) LI …

Primary chemotherapy to avoid mastectomy in tumors with diameters of three centimeters or more

…, F Rilke, S Andreola, R Silvestrini… - JNCI: Journal of the …, 1990 - academic.oup.com
In 165 women with breast cancer who were candidates for mastectomy because the largest
diameter of the tumor was 3 cm or more, we administered primary chemotherapy in the …

The Bcl-2 protein: a prognostic indicator strongly related to p53 protein in lymph node-negative breast cancer patients

R Silvestrini, S Veneroni, MG Daidone… - JNCI: Journal of the …, 1994 - academic.oup.com
Background The bcl-2 gene (also known as BCL2) encodes for a mitochondrial protein
thought to prevent apoptosis of normal cells. The protein has been detected by immunohis-…

p53 as an independent prognostic marker in lymph node-negative breast cancer patients

R Silvestrini, E Benini, MG Daidone… - JNCI: Journal of the …, 1993 - academic.oup.com
Background: At present, most decisions concerning the use of adjuvant therapy in lymph
node-negative breast cancer patients are made on the basis of traditional factors such as tumor …

Urine cell-free DNA integrity as a marker for early bladder cancer diagnosis: preliminary data

…, L Serra, E Scarpi, D Amadori, R Silvestrini… - … oncology: seminars and …, 2013 - Elsevier
Objectives Urine cell-free (UCF) DNA has recently been proposed as a potential marker for
early bladder cancer diagnosis. It is known that normal apoptotic cells produce highly …

[HTML][HTML] Peripheral blood miR-328 expression as a potential biomarker for the early diagnosis of NSCLC

…, G Foschi, M Mengozzi, E Scarpi, R Silvestrini… - International journal of …, 2013 - mdpi.com
Lung cancer is often diagnosed at an advanced stage, with subsequently poor prognosis.
There are no biomarkers available to facilitate early diagnosis or to discriminate between …

[HTML][HTML] Multiple marker detection in peripheral blood for NSCLC diagnosis

…, GL Casoni, E Scarpi, L Bucchi, R Silvestrini… - PloS one, 2013 - journals.plos.org
Background Non-invasive early detection of lung cancer could reduce the number of
patients diagnosed with advanced disease, which is associated with a poor prognosis. We …

p53 and bcl-2 expression correlates with clinical outcome in a series of node-positive breast cancer patients.

R Silvestrini, E Benini, S Veneroni… - Journal of clinical …, 1996 - ascopubs.org
BACKGROUND AND PURPOSE The tumor-suppressor gene TP53 and the proto-oncogene
bcl-2 encode, respectively, for a nuclear phosphoprotein and for a mitochondrial protein …

In vitro biological activity of Adriamycin

R Silvestrini, C Gambarucci, T Dasdia - Tumori Journal, 1970 - journals.sagepub.com
L'adriamicina è un antibiotico prodotto dallo « streptomyces peucetius » variazione « caesius
» con una struttura chimica molto simlie alla daunomicina ma con un più elevato indice …

Mitotic catastrophe and apoptosis induced by docetaxel in hormone‐refractory prostate cancer cells

…, I Vannini, C Arienti, W Zoli, R Silvestrini - Journal of cellular …, 2008 - Wiley Online Library
Studies performed in different experimental and clinical settings have shown that Docetaxel
(Doc) is effective in a wide range of tumors and that it exerts its activity through multiple …